Chemoinformaics analysis of n-Propyl 9,12-octadecadienoate
| Molecular Weight | 322.533 | nRot | 16 |
| Heavy Atom Molecular Weight | 284.229 | nRig | 3 |
| Exact Molecular Weight | 322.287 | nRing | 0 |
| Solubility: LogS | -3.765 | nHRing | 0 |
| Solubility: LogP | 5.802 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 61 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 62.0121 |
| nHD | 0 | BPOL | 40.7259 |
| QED | 0.178 |
| Synth | 2.37 |
| Natural Product Likeliness | 0.83 |
| NR-PPAR-gamma | 0.19 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.048 |
| CACO-2 | -4.889 |
| MDCK | 0.0000491 |
| BBB | 0.278 |
| PPB | 0.987204 |
| VDSS | 3.041 |
| FU | 0.0108191 |
| CYP1A2-inh | 0.428 |
| CYP1A2-sub | 0.227 |
| CYP2c19-inh | 0.478 |
| CYP2c19-sub | 0.069 |
| CYP2c9-inh | 0.361 |
| CYP2c9-sub | 0.949 |
| CYP2d6-inh | 0.595 |
| CYP2d6-sub | 0.864 |
| CYP3a4-inh | 0.768 |
| CYP3a4-sub | 0.109 |
| CL | 5.126 |
| T12 | 0.905 |
| hERG | 0.473 |
| Ames | 0.175 |
| ROA | 0.043 |
| SkinSen | 0.963 |
| Carcinogencity | 0.22 |
| EI | 0.69 |
| Respiratory | 0.662 |
| NR-Aromatase | 0.194 |
| Antiviral | No |
| Prediction | 0.564055 |